Note: Live price is not available for this stock. Showing closing price. For historical calculations, prices are adjusted for splits, bonus and rights issue. Percentage change shown is absolute irrespective of the period.
REMUS Stock Analysis
Views
Red Flags
Positive
Company is net cash
Negative
Expensive and at same valuation levels as industry median P/E
Weak price momentum
Low dividend yield
Neutral
Company's earnings are of moderate quality
Thinly traded (low daily turnover)
The stock is thinly traded with combined (NSE & BSE) daily turnover (21-day average) of 0.420395.
Snapshot
See detailed analysis
REMUS Shareholding Pattern
An overview of who owns the company. Click on chart icon to view historical movement.
REMUS Bulk, Block & Insider Trades
REMUS Dividends, Splits & Bonus
Dividend Events
Capital Change Events
Bonus
Bonus(1 new shares for 1 existing shares) Ex-date: 4th Jul 2025 Announced on: 17th May 2025
Bonus(3 new shares for 1 existing shares) Ex-date: 6th Jun 2024 Announced on: 23rd Apr 2024
Company Profile
Remus Pharmaceuticals Limited is an India-based company, which is engaged in marketing and distribution of finished formulations of pharmaceutical drugs. The Company also deals in active pharmaceutical ingredients (APIs). It also provides technical consultancy services to various distributors for pr... Read More
Key personnel
Incorporated on
Last Annual
Last Interim
No. of Employees
IPO date
Free Float
Website
Phone no.
Address
Frequently asked questions
What is the current share price of Remus Pharmaceuticals Ltd.?
The current share price of Remus Pharmaceuticals Ltd. is ₹ 704.55 as of 09 Jan 2026.
What is the PE ratio of Remus Pharmaceuticals Ltd.?
The Price-to-Earnings (PE) ratio of Remus Pharmaceuticals Ltd. is 28.56 as of the latest financial data.
What is the ROE and ROCE of Remus Pharmaceuticals Ltd.?
Remus Pharmaceuticals Ltd. has a Return on Equity (ROE) of 16.96% and a Return on Capital Employed (ROCE) of 20.80% as per the latest financial reports.
What is the market cap of Remus Pharmaceuticals Ltd.?
The market capitalization of Remus Pharmaceuticals Ltd. stands at ₹ 830.24 Cr.
What is the dividend yield of Remus Pharmaceuticals Ltd.?
The dividend yield of Remus Pharmaceuticals Ltd. is 0.14% based on the current market price.
What is the RSI of Remus Pharmaceuticals Ltd.?
The Relative Strength Index (RSI) of Remus Pharmaceuticals Ltd. is 46.36.
What is the FII and DII holding in Remus Pharmaceuticals Ltd.?
Foreign Institutional Investors (FII) hold 5.02% and Domestic Institutional Investors (DII) hold 0.00% of Remus Pharmaceuticals Ltd. shares.
What sector does Remus Pharmaceuticals Ltd. belong to?
Remus Pharmaceuticals Ltd. operates in the Healthcare sector.
What is the beta of Remus Pharmaceuticals Ltd. stock?
The beta of Remus Pharmaceuticals Ltd. stock is 1.06, indicating its volatility relative to the broader market.
